A vaccine targeting the Bundibugyo strain of Ebola is reportedly nearing clinical trials. This vaccine aims to be the first treatment available for this particular deadly strain. Although it has not yet been tested on humans, efforts are advancing to move it into the trial phase. Successful development could change the landscape of Ebola treatment significantly.
Researchers Escorted Out of Diabetes Conference for Criticizing Trump Administration 
Ebola Outbreak in Africa: A Serious Concern 
Gold and the Ebola Outbreak in Congo’s Mining Towns 
House Passes Bill for Veterans’ Benefit Increase 
Gene Editing in Human Embryos at Columbia University 
Melinda French Gates Commits $215 Million for Global Women’s Health